TABLE 1.

Strains tested in this study and their previously published^a resistance mechanisms

Patient	Isolate	Efflux pumpb expression level	ERG11 point mutation(s)
I	C23		S405F heterozygote
I	C32	No increase relative to C23	No data
I	C39	Increased CDR1 and CDR2 signals relative to C23	S405F homozygote
II	C45
II	C18	No increase relative to C45
II	C46	No increase relative to C45
III	C33
III	C34	No increase relative to C33	S405F homozygote
III	C26	Increased CDR1 and CDR2 signals relative to C33	S405F and Y132H homozygote
III	C82	Less pronounced increase in CDR1 and CDR2 signals relative to C33	S405F homozygote
IV	C27
IV	C37	No increase relative to C27	G464S and R467K homozygote
IV	C40	Increased CaMDR1 signal relative to C27	G464S and R467K homozygote, Y132H heterozygote
V	C43		G129A heterozygote
V	C48	Increased CDR1 and CDR2 signals relative to C43	No data
V	C56	Increased CDR1 and CDR2 signals relative to C43	G129A and G464S homozygote

^aReferences 27 and 29 to 31. 

^bCDR1, CDR2, and CaMDR1.